Czech Republic To Assess Impact Of National Drug Shortage Measures In The EU
EU member states told the latest meeting of a European Commission advisory committee about steps they have taken to deal with drug shortages, including export bans, prescribing restrictions, the establishment of “national safety stocks,” and specific requirements on marketing authorization holders.
You may also be interested in...
All product classes are affected by supply chain issues, with drugs for the cardiovascular and nervous systems, anti-infectives and anticancer drugs particularly at risk, says the French regulator.
The European Commission says the collective actions it is proposing should allow it to work more closely with the pharmaceutical industry and help EU member states improve the security of medicines supply.
New EU guidance will cover non-clinical and clinical development, trial design, endpoints, safety issues and comparators, as well as the use of immunobridging studies.